Increased IFN-β secretion inhibits NSCLC cell proliferation and increases the infiltration levels of CD4+ T cells, M1 macrophages and NK cells into the tumor microenvironment, consequently inhibiting NSCLC progression. This evidence concerns the gene IFNB1 and non-small cell lung carcinoma.